227 related articles for article (PubMed ID: 22713615)
1. A reappraisal of plasma, prothrombin complex concentrates, and recombinant factor VIIa in patient blood management.
Goodnough LT
Crit Care Clin; 2012 Jul; 28(3):413-26, vi-vii. PubMed ID: 22713615
[TBL] [Abstract][Full Text] [Related]
2. Rapid reversal of warfarin-associated hemorrhage in the emergency department by prothrombin complex concentrates.
Frumkin K
Ann Emerg Med; 2013 Dec; 62(6):616-626.e8. PubMed ID: 23829955
[TBL] [Abstract][Full Text] [Related]
3. Hemostatic agents for bleeding: recombinant-activated factor VII and beyond.
Franchini M; Crestani S; Frattini F; Sissa C; Bonfanti C
Semin Thromb Hemost; 2015 Apr; 41(3):342-7. PubMed ID: 24937097
[TBL] [Abstract][Full Text] [Related]
4. The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disorders.
Ragni MV
Hematology Am Soc Hematol Educ Program; 2013; 2013():44-51. PubMed ID: 24319161
[TBL] [Abstract][Full Text] [Related]
5. Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products.
Tang M; Fenger-Eriksen C; Wierup P; Greisen J; Ingerslev J; Hjortdal V; Sørensen B
Thromb Res; 2017 Jun; 154():73-79. PubMed ID: 28437748
[TBL] [Abstract][Full Text] [Related]
6. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
Le Roux P; Pollack CV; Milan M; Schaefer A
J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of recombinant activated factor VII vs. plasma-derived activated prothrombin complex concentrate in the treatment of mild-to-moderate bleeding episodes in patients with severe haemophilia A and inhibitors in Spain.
Jimenez-Yuste V; Núñez R; Romero JA; Montoro B; Espinós B
Haemophilia; 2013 Nov; 19(6):841-6. PubMed ID: 23758100
[TBL] [Abstract][Full Text] [Related]
8. Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.
Guzzetta NA; Russell IA; Williams GD
Anesth Analg; 2012 Aug; 115(2):364-78. PubMed ID: 22652310
[TBL] [Abstract][Full Text] [Related]
9. Retrospective study of rFVIIa, 4-factor PCC, and a rFVIIa and 3-factor PCC combination in improving bleeding outcomes in the warfarin and non-warfarin patient.
DeLoughery E; Avery B; DeLoughery TG
Am J Hematol; 2016 Jul; 91(7):705-8. PubMed ID: 27074566
[TBL] [Abstract][Full Text] [Related]
10. Transfusion interventions in critical bleeding requiring massive transfusion: a systematic review.
McQuilten ZK; Crighton G; Engelbrecht S; Gotmaker R; Brunskill SJ; Murphy MF; Wood EM
Transfus Med Rev; 2015 Apr; 29(2):127-37. PubMed ID: 25716645
[TBL] [Abstract][Full Text] [Related]
11. Emerging off-label uses for recombinant activated factor VII: grading the evidence.
Enomoto TM; Thorborg P
Crit Care Clin; 2005 Jul; 21(3):611-32. PubMed ID: 15992675
[TBL] [Abstract][Full Text] [Related]
12. The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding.
Fries D
Transfusion; 2013 Jan; 53 Suppl 1():91S-95S. PubMed ID: 23301979
[TBL] [Abstract][Full Text] [Related]
13. Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting.
Ghadimi K; Levy JH; Welsby IJ
Anesth Analg; 2016 May; 122(5):1287-300. PubMed ID: 26983050
[TBL] [Abstract][Full Text] [Related]
14. Perioperative use of prothrombin complex concentrates.
Colomina MJ; Díez Lobo A; Garutti I; Gómez-Luque A; Llau JV; Pita E
Minerva Anestesiol; 2012 Mar; 78(3):358-68. PubMed ID: 22357373
[TBL] [Abstract][Full Text] [Related]
15. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion.
Aguilar MI; Hart RG; Kase CS; Freeman WD; Hoeben BJ; García RC; Ansell JE; Mayer SA; Norrving B; Rosand J; Steiner T; Wijdicks EF; Yamaguchi T; Yasaka M
Mayo Clin Proc; 2007 Jan; 82(1):82-92. PubMed ID: 17285789
[TBL] [Abstract][Full Text] [Related]
16. The clinical use of prothrombin complex concentrate.
Ferreira J; DeLosSantos M
J Emerg Med; 2013 Jun; 44(6):1201-10. PubMed ID: 23602147
[TBL] [Abstract][Full Text] [Related]
17. Prothrombin complex concentrate for critical bleeding.
Patanwala AE; Acquisto NM; Erstad BL
Ann Pharmacother; 2011 Jul; 45(7-8):990-9. PubMed ID: 21730276
[TBL] [Abstract][Full Text] [Related]
18. Control of bleeding in patients with haemophilia A with inhibitors: a systematic review.
Lloyd Jones M; Wight J; Paisley S; Knight C
Haemophilia; 2003 Jul; 9(4):464-520. PubMed ID: 12828680
[TBL] [Abstract][Full Text] [Related]
19. Key concepts in the management of difficult hemorrhagic cases.
MacLaren R
Pharmacotherapy; 2007 Sep; 27(9 Pt 2):93S-102S. PubMed ID: 17723112
[TBL] [Abstract][Full Text] [Related]
20. Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders.
Selin S; Tejani A
Issues Emerg Health Technol; 2006 Mar; (82):1-4. PubMed ID: 16602203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
